Nucleocapsid protein

Nucleocapsid protein Informations sur la molécule

Nom anglais	Nucleocapsid proteins	Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	2	Alias de la cible	Nucleocapsid Proteins
Phase de R&D la plus avancée	Phase 2 Clinical

Nom anglais	Nucleocapsid proteins
Alias de la cible	Nucleocapsid Proteins
Nombre de médicaments commercialisés	0
Nombre de médicaments cliniques	2
Phase de R&D la plus avancée	Phase 2 Clinical

Nucleocapsid protein Liste de produits

Attribut
Protein (20)Kits (1)
Bibliothèque de produits
En ligne (21)
Espèces
SARS-CoV-2 (15)MERS (1)SARS (1)HCoV-NL63 (1)HCoV-OC43 (1)HCoV-229E (1)SFTS virus (1)
Étiquette
His Tag (18)His Tag & Avi Tag (2)- (1)
Marqueur
Unconjugated (18)Biotin-labeled (2)- (1)

Numéro de produit	Espèces	Système d'expression	Description du produit	Pré-commande/Commande
HOT NUN-C51H9	SARS-CoV-2	E. coli	SARS-CoV-2 (COVID-19) Nucleocapsid protein, His Tag	Ajouter au panier
HOT NUN-C5227	SARS-CoV-2	HEK293	SARS-CoV-2 (COVID-19) Nucleocapsid protein, His Tag	Ajouter au panier
HOT NUN-C52Hu	SARS-CoV-2	HEK293	SARS-CoV-2 Nucleocapsid protein, His Tag (BA.2&BA.3/Omicron)	Ajouter au panier
NUN-C5143	SARS-CoV-2	E. coli	SARS-CoV-2 Nucleocapsid Protein NTD, His Tag (MALS verified)	Ajouter au panier
NUN-C5145	SARS-CoV-2	E. coli	SARS-CoV-2 Nucleocapsid Protein CTD, His Tag (MALS verified)	Ajouter au panier
NUN-C51H2	SARS-CoV-2	E. coli	SARS-CoV-2 (COVID-19) Nucleocapsid protein, His Tag	Ajouter au panier
NUN-C5221	SARS-CoV-2	HEK293	SARS-CoV-2 (COVID-19) Nucleocapsid protein, His Tag	Ajouter au panier
NUN-C52H8	SARS-CoV-2	HEK293	SARS-CoV-2 Nucleocapsid protein (D3L, R203K, G204R, S235F), His Tag	Ajouter au panier
NUN-C52Hr	SARS-CoV-2	HEK293	SARS-CoV-2 Nucleocapsid protein (D63G, R203M, G215C, D377Y), His Tag	Ajouter au panier
NUN-C52Ht	SARS-CoV-2	HEK293	SARS-CoV-2 Nucleocapsid protein, His Tag (B.1.1.529/Omicron)	Ajouter au panier

Quantité totale21

Nucleocapsid proteinContexte de la molécule

The nucleocapsid (NP) protein of Severe Fever with Thrombocytopenia Syndrome virus (SFTSV) is encoded by the S segment of its tripartite RNA genome. NP plays a central role in viral replication by encapsidating the genomic RNA and forming ribonucleoprotein complexes with the polymerase. It is highly conserved among SFTSV strains and strongly immunogenic, making it a major target for diagnostic assays and serological studies. Because of its abundance and stability, recombinant NP is widely used as an antigen for ELISA, rapid tests, and antibody development against this emerging tick-borne phlebovirus.

Nucleocapsid proteinAlias de la molécule

Nucleocapsid protein,NP,Protein N

Informations sur les médicaments cliniques

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Indication	Essai clinique
Zelicapavir	EDP-938; EP-023938	Phase 2 Clinical	Enanta Pharmaceuticals Inc	Respiratory Syncytial Virus Infections	Details
PF-07923567	RV-299; PF-07923567	Phase 1 Clinical	Reviral Ltd	Respiratory Syncytial Virus Infections	Details